Beijing Tongrentang Co Ltd (600085) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills.
Total Assets Chart for Beijing Tongrentang Co Ltd
Beijing Tongrentang Co Ltd (600085) total assets for FY2025 were CNY 30.6B, a -1.8% change from FY2024. Beijing Tongrentang Co Ltd's total assets grew from CNY 635.4M in 1994 to CNY 30.6B in 2025 (4719.5% over 31 years). Total assets compound annual growth rate: 5-year CAGR of 7.0%, 10-year CAGR of 7.9%, 20-year CAGR of 11.0%.
Total Assets (CNY)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ¥33.11B
- Implied Share Price
- ¥24.14
- Enterprise Value
- ¥25.33B
- Revenue (TTM)
- ¥15.87B
- EBITDA
- ¥1.79B
- Profit Margin
- 6.11%
- Trailing P/E
- 34.00
- Forward P/E
- 28.17
- Price/Book (MRQ)
- 2.40
- Price/Sales (TTM)
- 2.09
- EV/EBITDA
- 9.12
- EV/Revenue
- 1.58
- Dividend Yield
- 4.19%
- Book Value
- ¥9.93
- Free Cash Flow (FY2025)
- ¥2.34B
- Free Cash Flow Yield
- 7.05%
Snapshot as of 5th September 2026 — not point-in-time controlled, may lag the live market by a few days.